MYC and hepatocellular carcinoma: The miR-302-mediated iPSC technology by Koga et al. caused H3K4 methylation and c-Myc suppression through AOF2 downregulation, reprogramming hepatocellular carcinoma (HCC) cells, and improving drug sensitivity [31].